NOTES PAYABLE (Details Narrative) | Jan. 12, 2017USD ($)$ / sharesshares | Dec. 12, 2016USD ($)$ / sharesshares | Nov. 01, 2016USD ($)$ / sharesshares | Sep. 02, 2016USD ($)$ / sharesshares | Jul. 01, 2016USD ($)$ / sharesshares | Mar. 06, 2013USD ($)Number | May 31, 2018USD ($)$ / sharesshares | Feb. 28, 2018USD ($)$ / sharesshares | Nov. 30, 2017USD ($)$ / sharesshares | Aug. 31, 2017USD ($)$ / sharesshares | May 31, 2017USD ($)$ / sharesshares | May 31, 2017USD ($)$ / shares | Aug. 31, 2017USD ($)$ / shares |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Current portion of note payable | | | | | | | $ 260,387 | | | $ 260,387 | | | $ 260,387 |
Amortization of debt discount | | | | | | | | | | | | $ 23,650 | |
Impairment of mineral properties | | | | | | | | | | | | | 1,394,852 |
Foundation Lease Note Payable [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Periodic payment | | | | | | $ 45,000 | | | | | | | |
Number of payments | Number | | | | | | 9 | | | | | | | |
Imputed interest rate | | | | | | 5.00% | | | | | | | |
Note payable face amount | | | | | | $ 364,852 | | | | | | | |
Current portion of note payable | | | | | | | 260,000 | | | | | | |
Accrued interest payable | | | | | | | 44,000 | | | | | | |
Amount of lease payment in default | | | | | | | 45,000 | | | | | | |
Director Loans 7/1/2016 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | | | 2 | | | | | | | | |
Number of directors | | | | | 2 | | | | | | | | |
Note payable face amount | | | | | $ 2,500 | | | | | | | | |
Notes payable - related party, net of discounts | | | | | | | 5,000 | | | 5,000 | | | 5,000 |
Common stock warrants granted | shares | | | | | 5,000 | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | $ 0.10 | | | | | | | | |
Warrant term | | | | | 5 years | | | | | | | | |
Fair value of warrants | | | | | $ 1,185 | | | | | | | | |
Expected life | | | | | 5 years | | | | | | | | |
Expected volatility | | | | | 185.00% | | | | | | | | |
Risk-free interest rate | | | | | 1.00% | | | | | | | | |
Expected dividend yield | | | | | 0.00% | | | | | | | | |
Director Loans 9/1/2016 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | | 5 | | | | | | | | | |
Number of directors | | | | 5 | | | | | | | | | |
Note payable face amount | | | | $ 71,500 | | | | | | | | | |
Notes payable - related party, net of discounts | | | | | | | 71,500 | | | 71,500 | | | 71,500 |
Common stock warrants granted | shares | | | | 147,000 | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | $ 0.10 | | | | | | | | | |
Warrant term | | | | 5 years | | | | | | | | | |
Fair value of debt | | | | $ 57,414 | | | | | | | | | |
Fair value of warrants | | | | $ 14,086 | | | | | | | | | |
Expected life | | | | 5 years | | | | | | | | | |
Expected volatility | | | | 245.00% | | | | | | | | | |
Risk-free interest rate | | | | 1.18% | | | | | | | | | |
Expected dividend yield | | | | 0.00% | | | | | | | | | |
Director Loan 11/1/2016 #1 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Note payable face amount | | | $ 4,000 | | | | | | | | | | |
Common stock warrants granted | shares | | | 8,000 | | | | | | | | | | |
Director Loan 11/1/2016 #2 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Note payable face amount | | | $ 1,000 | | | | | | | | | | |
Common stock warrants granted | shares | | | 2,000 | | | | | | | | | | |
Director Loans 11/1/2016 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | 2 | | | | | | | | | | |
Number of directors | | | 2 | | | | | | | | | | |
Notes payable - related party, net of discounts | | | | | | | 5,000 | | | 5,000 | | | 5,000 |
Warrants, exercise price | $ / shares | | | $ 0.10 | | | | | | | | | | |
Warrant term | | | 5 years | | | | | | | | | | |
Fair value of warrants | | | $ 1,057 | | | | | | | | | | |
Expected life | | | 5 years | | | | | | | | | | |
Expected volatility | | | 181.00% | | | | | | | | | | |
Risk-free interest rate | | | 1.30% | | | | | | | | | | |
Expected dividend yield | | | 0.00% | | | | | | | | | | |
Director Loan 12/12/2016 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Note payable face amount | | $ 15,000 | | | | | | | | | | | |
Notes payable - related party, net of discounts | | | | | | | 15,000 | | | 15,000 | | | 15,000 |
Maturity date | | Jun. 12, 2017 | | | | | | | | | | | |
Common stock warrants granted | shares | | 60,000 | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | $ 0.10 | | | | | | | | | | | |
Warrant term | | 5 years | | | | | | | | | | | |
Fair value of debt | | $ 10,467 | | | | | | | | | | | |
Fair value of warrants | | $ 4,563 | | | | | | | | | | | |
Expected life | | 5 years | | | | | | | | | | | |
Expected volatility | | 241.00% | | | | | | | | | | | |
Risk-free interest rate | | 1.90% | | | | | | | | | | | |
Expected dividend yield | | 0.00% | | | | | | | | | | | |
Director and Officer Loans 1/12/2017 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | 2 | | | | | | | | | | | | |
Note payable face amount | $ 20,000 | | | | | | | | | | | | |
Notes payable - related party, net of discounts | | | | | | | 20,000 | | | 20,000 | | | 20,000 |
Maturity date | Jul. 12, 2017 | | | | | | | | | | | | |
Common stock warrants granted | shares | 40,000 | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | $ 0.10 | | | | | | | | | | | | |
Warrant term | 5 years | | | | | | | | | | | | |
Fair value of debt | $ 13,542 | | | | | | | | | | | | |
Fair value of warrants | $ 6,458 | | | | | | | | | | | | |
Expected life | 5 years | | | | | | | | | | | | |
Expected volatility | 240.00% | | | | | | | | | | | | |
Risk-free interest rate | 1.87% | | | | | | | | | | | | |
Expected dividend yield | 0.00% | | | | | | | | | | | | |
Director Loans Qtr 5/31/2017 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | | | | | | | | | 8 | 8 | |
Number of directors | | | | | | | | | | | 2 | 2 | |
Note payable face amount | | | | | | | | | | | $ 47,500 | $ 47,500 | |
Notes payable - related party, net of discounts | | | | | | | 47,500 | | | $ 47,500 | | | $ 47,500 |
Common stock warrants granted | shares | | | | | | | | | | | 190,000 | | |
Warrant term | | | | | | | | | | | 5 years | | |
Fair value of warrants | | | | | | | | | | | $ 39,557 | $ 39,557 | |
Expected life | | | | | | | | | | | 5 years | | |
Expected volatility | | | | | | | | | | | 234.00% | | |
Risk-free interest rate | | | | | | | | | | | 1.75% | | |
Expected dividend yield | | | | | | | | | | | 0.00% | | |
Director Loans Qtr 5/31/2017 [Member] | Lower Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | | | | $ 0.17 | $ 0.17 | |
Director Loans Qtr 5/31/2017 [Member] | Upper Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | | | | $ 0.21 | $ 0.21 | |
Director Loans Qtr 8/31/2017 [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | | | | | | | | 7 | | | 7 |
Number of directors | | | | | | | | | | 2 | | | 2 |
Note payable face amount | | | | | | | | | | $ 82,165 | | | $ 82,165 |
Notes payable - related party, net of discounts | | | | | | | $ 82,165 | | | $ 82,165 | | | 82,165 |
Common stock warrants granted | shares | | | | | | | | | | 328,660 | | | |
Warrant term | | | | | | | | | | 5 years | | | |
Fair value of warrants | | | | | | | | | | $ 65,137 | | | $ 65,137 |
Expected life | | | | | | | | | | 5 years | | | |
Expected volatility | | | | | | | | | | 169.00% | | | |
Risk-free interest rate | | | | | | | | | | 1.75% | | | |
Expected dividend yield | | | | | | | | | | 0.00% | | | |
Director Loans Qtr 8/31/2017 [Member] | Lower Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | | | $ 0.20 | | | $ 0.20 |
Director Loans Qtr 8/31/2017 [Member] | Upper Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | | | $ 0.23 | | | $ 0.23 |
Advances - Director and Officer [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | | | | | 5 | | | | | | |
Number of directors | | | | | | | 2 | | | | | | |
Note payable face amount | | | | | | | $ 34,500 | | | | | | |
Notes payable - related party, net of discounts | | | | | | | 34,500 | | | | | | |
Common stock warrants granted | shares | | | | | | | | 138,000 | | | | | |
Warrant term | | | | | | | | 5 years | | | | | |
Expected life | | | | | | | | 5 years | | | | | |
Expected volatility | | | | | | | | 122.00% | | | | | |
Risk-free interest rate | | | | | | | | 2.88% | | | | | |
Expected dividend yield | | | | | | | | 0.00% | | | | | |
Advances - Director and Officer [Member] | Lower Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | $ 0.15 | | | | | |
Fair value of warrants | | | | | | | | $ 24,520 | | | | | |
Advances - Director and Officer [Member] | Upper Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | $ .21 | | | | | |
Advances - Director and Officer [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | | | | | | | 2 | | | | |
Note payable face amount | | | | | | | | | $ 16,750 | | | | |
Notes payable - related party, net of discounts | | | | | | | $ 16,750 | | $ 16,750 | | | | |
Common stock warrants granted | shares | | | | | | | | | 67,000 | | | | |
Warrant term | | | | | | | | | 5 years | | | | |
Fair value of warrants | | | | | | | | | $ 12,518 | | | | |
Expected life | | | | | | | | | 5 years | | | | |
Expected volatility | | | | | | | | | 122.00% | | | | |
Risk-free interest rate | | | | | | | | | 2.88% | | | | |
Expected dividend yield | | | | | | | | | 0.00% | | | | |
Advances - Director and Officer [Member] | Lower Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | | $ 0.21 | | | | |
Advances - Director and Officer [Member] | Upper Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | | | $ 0.22 | | | | |
Advances - Director [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Number of loans | | | | | | | 4 | | | | | | |
Note payable face amount | | | | | | | $ 24,000 | | | | | | |
Notes payable - related party, net of discounts | | | | | | | $ 24,000 | | | | | | |
Common stock warrants granted | shares | | | | | | | 96,000 | | | | | | |
Warrant term | | | | | | | 5 years | | | | | | |
Fair value of warrants | | | | | | | $ 16,436 | | | | | | |
Expected life | | | | | | | 5 years | | | | | | |
Expected volatility | | | | | | | 224.00% | | | | | | |
Risk-free interest rate | | | | | | | 2.88% | | | | | | |
Expected dividend yield | | | | | | | 0.00% | | | | | | |
Advances - Director [Member] | Lower Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | $ .17 | | | | | | |
Advances - Director [Member] | Upper Range [Member] | | | | | | | | | | | | | |
Debt Instrument [Line Items] | | | | | | | | | | | | | |
Warrants, exercise price | $ / shares | | | | | | | $ .19 | | | | | | |